Cite
Triple Intrathecal Combination Therapy for End-Stage Cancer-Related Refractory Pain: A Prospective Observational Study with Two-Month Follow-Up
MLA
Lidia Dalfino, et al. “Triple Intrathecal Combination Therapy for End-Stage Cancer-Related Refractory Pain: A Prospective Observational Study with Two-Month Follow-Up.” Pain and Therapy, vol. 9, Apr. 2020, pp. 783–92. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7c753f9be20911cc04ddfde6ed01368a&authtype=sso&custid=ns315887.
APA
Lidia Dalfino, Nicola Brienza, Mariateresa Giglio, Francesco Bruno, Giustino Varrassi, Angela Preziosa, & Filomena Puntillo. (2020). Triple Intrathecal Combination Therapy for End-Stage Cancer-Related Refractory Pain: A Prospective Observational Study with Two-Month Follow-Up. Pain and Therapy, 9, 783–792.
Chicago
Lidia Dalfino, Nicola Brienza, Mariateresa Giglio, Francesco Bruno, Giustino Varrassi, Angela Preziosa, and Filomena Puntillo. 2020. “Triple Intrathecal Combination Therapy for End-Stage Cancer-Related Refractory Pain: A Prospective Observational Study with Two-Month Follow-Up.” Pain and Therapy 9 (April): 783–92. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7c753f9be20911cc04ddfde6ed01368a&authtype=sso&custid=ns315887.